Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Samidirect is the direct selling subsidiary of the Sami-Sabinsa Group, an international research-oriented health science company. The company specializes in the commercialization of nutraceuticals, cosmeceuticals, and functional food products derived from standardized herbal extracts. Its product portfolio is built upon the extensive research and intellectual property of Sami Labs, which holds hundreds of global patents for ingredients like Curcumin C3 Complex and BioPerine. Samidirect operates through a multi-level marketing model, primarily serving the Indian market while expanding its footprint globally. The company's offerings focus on various health segments, including weight management, joint support, and skin care. By bridging the gap between traditional Ayurvedic wisdom and modern clinical research, Samidirect provides evidence-based wellness solutions to a broad consumer base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Samidirect.